B LYNNE PARSHALL
CIK 1073385 · COO · last filed 2026-06-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.12M
Companies
7
Total Filings
188
Lifetime Open-Market Net
-$93.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FHTX | Director | — | $6.07 | — | $0 | 5 | 2026-06-25 |
| CYTK | Director | 15,784 | $76.76 | $1.21M | -$7.72M | 38 | 2026-06-01 |
| IONS | Director | 51,344 | $56.56 | $2.90M | -$17.94M | 43 | 2026-04-17 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Director | — | — | — | $0 | 5 | 2020-10-13 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | COO & Secretary | 13,143 | — | — | -$24.74M | 59 | 2015-11-09 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 104,715 | $8.16 | $854.5K | -$42.66M | 17 | 2014-11-05 |
| CARDIODYNAMICS INTERNATIONAL CORP (CDIC) Delisted | Director | 0 | — | — | $0 | 4 | 2009-08-14 |
Recent Filings · Page 13 of 19
188 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-09-12 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −17,800 | -$139.8K | EDGAR |
| 2014-09-05 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −20,100 | -$142.2K | EDGAR |
| 2014-09-04 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$332.9K | EDGAR |
| 2014-08-29 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,000 | -$70.0K | EDGAR |
| 2014-08-22 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −21,500 | -$148.2K | EDGAR |
| 2014-08-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,900 | -$76.5K | EDGAR |
| 2014-08-08 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −15,200 | -$104.4K | EDGAR |
| 2014-08-01 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,700 | -$68.0K | EDGAR |
| 2014-07-18 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −27,000 | -$179.9K | EDGAR |
| 2014-07-11 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −16,100 | -$108.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.